Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(204)
Steven J. Jacobsen
31
Michael M. Lieber
21
Harry A. Guess
21
Cynthia J. Girman
14
Christopher G. Chute
12
Journals
(21)
Urology
55
J UROL
34
CURR OPIN UROL
7
JAMA-J AM MED ASSN
4
N ENGL J MED
4
Keywords
(122)
Embed
Subscribe
Academic
Authors
Joseph E. Oesterling
Joseph E. Oesterling,University of Michigan,Urology,Anatomy,Endocrinology
Edit
Joseph E. Oesterling
University of Michigan
Publications:
136
|
Citations:
4360
Fields:
Urology
,
Anatomy
,
Endocrinology
View FAQ about top research areas and Fields of study
Collaborated with
204 co-authors
from 1990 to 2010
|
Cited by
8653 authors
Cumulative
Annual
Sort by:
Publications
(136)
BibTeX
|
RIS
|
RefWorks
Download
Serum Prostate-Specific Antigen in a Community-Based Population of Healthy Men Establishment of Age-Specific Reference Ranges
(
Citations: 103
)
Joseph E. Oesterling
,
Steven J. Jacobsen
,
Christopher G. Chute
,
Harry A. Guess
,
Cynthia J. Girman
,
Laurei A. Panser
,
Michael M. Lieber
Published in 2010.
DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUM
(
Citations: 37
)
CHARLOTTE BECKER
,
TIMO PIIRONEN
,
KIM PETTERSSON
,
THOMAS BJöRK
,
KIRK J. WOJNO
,
JOSEPH E. OESTERLING
,
HANS LILJA
Journal:
Journal of Urology - J UROL
, vol. 163, no. 1, pp. 311-316, 2000
DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUM
(
Citations: 7
)
CHARLOTTE BECKER
,
TIMO PIIRONEN
,
KIM PETTERSSON
,
KIRK J. WOJNO
,
JOSEPH E. OESTERLING
,
HANS LILJA
Journal:
Journal of Urology - J UROL
, vol. 164, no. 6, 2000
HAVE COMPLICATION RATES DECREASED AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER?
(
Citations: 22
)
IAN M. THOMPSON
,
RICHARD G. MIDDLETON
,
SCOTT A. OPTENBERG
,
MARK S. AUSTENFELD
,
STEPHEN R. SMALLEY
,
WILLIAM H. COONER
,
ROY J. CORREA
,
HARRY C. MILLER
,
JOSEPH E. OESTERLING
,
MARTIN I. RESNICK
,
JOHN H. WASSON
,
CLAUS G. ROEHRBORN
Journal:
Journal of Urology - J UROL
, vol. 162, no. 1, pp. 107-112, 1999
Screening Digital Rectal Examination and Prostate Cancer Mortality: A Population-Based Case-Control Study
S. J. Jacobsen
,
E. J. Bergstralh
,
S. K. Katusic
,
H. A. Guess
,
C. H. Darby
,
M. D. Silverstein
,
J. E. Oesterling
,
M. M. Lieber
Journal:
Journal of Urology - J UROL
, vol. 161, no. 1, pp. 353-353, 1999
Sort by:
Citations
(4360 times by 3196 publications)
Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis
J S Richards
,
H-Y Fan
,
Z Liu
,
M Tsoi
,
M-N Laguë
,
A Boyer
,
D Boerboom
Journal:
Oncogene
, vol. 31, no. 12, pp. 1504-1520, 2012
Androgen deprivation therapy-associated vasomotor symptoms
Jason M Jones
,
Manish Kohli
,
Charles L Loprinzi
Journal:
Asian Journal of Andrology - ASIAN J ANDROL
, vol. 14, no. 2, pp. 193-197, 2012
Association of GPX1 polymorphism, GPX activity and prostate cancer risk
O Erdem
,
A Eken
,
C Akay
,
Z Arsova-Sarafinovska
,
N Matevska
,
L Suturkova
,
K Erten
,
Y Özgök
,
A Dimovski
,
A Sayal
,
A Aydın
Journal:
Human & Experimental Toxicology - HUM EXP TOXICOL
, vol. 31, no. 1, pp. 24-31, 2012
Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy
S A Boorjian
,
M K Tollefson
,
L J Rangel
,
E J Bergstralh
,
R J Karnes
Journal:
Prostate Cancer and Prostatic Diseases - PROSTATE CANCER PROSTATIC DIS
, vol. 15, no. 1, pp. 56-62, 2012
Radionuclide and hybrid imaging of recurrent prostate cancer
(
Citations: 5
)
Ambros J Beer
,
Matthias Eiber
,
Michael Souvatzoglou
,
Markus Schwaiger
,
Bernd Joachim Krause
Journal:
Lancet Oncology - LANCET ONCOL
, vol. 12, no. 2, pp. 181-191, 2011
Comments